Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy - Université de Rennes Access content directly
Journal Articles European Urology Year : 2016

Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy

Michael Staehler
  • Function : Author
Steven E. Canfield
  • Function : Author
Saeed Dabestani
  • Function : Author
Rachel Giles
  • Function : Author
Fabian Hofmann
  • Function : Author
Markus A. Kuczyk
  • Function : Author
Thomas Lam
  • Function : Author
Lorenzo Marconi
  • Function : Author
Axel S. Merseburger
  • Function : Author
Alessandro Volpe
  • Function : Author
  • PersonId : 868747

Abstract

The European Association of Urology renal cancer guidelines have been updated to recommend nivolumab and cabozantinib over the previous standard of care in patients who have failed one or more lines of VEGF targeted therapy.
No file

Dates and versions

hal-01220642 , version 1 (26-10-2015)

Identifiers

Cite

Thomas Powles, Michael Staehler, Börje Ljungberg, Karim Bensalah, Steven E. Canfield, et al.. Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy. European Urology, 2016, 69 (1), pp.4-6. ⟨10.1016/j.eururo.2015.10.017⟩. ⟨hal-01220642⟩
58 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More